Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson & Johnson Collaborates With China MOH On Cardiology Training And Authentication

This article was originally published in PharmAsia News

Executive Summary

Johnson & Johnson Medical (China) and International Health Exchange and Cooperation Center under China's Ministry of Health have signed an agreement on Chinese physician training for cardiology intervention diagnosis and treatment. Sponsored by Johnson & Johnson and guided by the ministry's Medical Administration Department, the three-year program will conduct standardized training and authentication for local cardiology intervention physicians. Johnson & Johnson's Cordis College and MOH will jointly establish a training system for cardiology diseases, complemented by physician practice license authentication. The uniquely Chinese program will be standardized and systematic, in line with international practices, so as to promote medical quality and ensure safety. (Click here for more - Chinese language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071530

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel